Analyst firms · BTIG · VSTM
BTIG VSTM price target and rating history
Verastem Inc. (VSTM) · Health Care
BTIG rates Verastem Inc. (VSTM) Buy with a $19 price target, as of its latest action on Mar 12, 2026. It has published 3 rating actions on VSTM since November 2023, including 0 upgrades and 0 downgrades.
- Current rating
- Buy
- Price target
- $19
- Median target, all firms
- Too few
- Actions on VSTM
- 3
BTIG price target on VSTM
Every BTIG rating on VSTM
- Mar 12, 2026
- Dec 31, 2024
- Nov 21, 2023
How other firms rate VSTM
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Wolfe Research | Outperform | Sep 17, 2026 | |
| BTIG | Buy | $19 | Mar 12, 2026 |
| H.C. Wainwright | Buy | $18 | Feb 4, 2026 |
Questions about BTIG and VSTM
- What is BTIG's price target for VSTM?
- BTIG's latest stated price target for Verastem Inc. (VSTM) is $19, from its action on Mar 12, 2026.
- What is BTIG's rating on VSTM?
- BTIG rates VSTM Buy, a bullish rating, as of Mar 12, 2026.
- When did BTIG last change its view on VSTM?
- On Mar 12, 2026, BTIG resumes coverage at Buy, price target $19.
More VSTM rating histories
All BTIG ratingsVSTM news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.